Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial

Abstract Background and objectives: The weight parameters for use of sugammadex in morbidly obese patients still need to be defined. Methods: A prospective clinical trial was conducted with sixty participants with body mass index ≥ 40 kg.m-2 during bariatric surgery, randomized into three groups:...

Full description

Bibliographic Details
Main Authors: Nádia Maria da Conceição Duarte, Ana Maria Menezes Caetano, Silvio da Silva Caldas Neto, Getúlio Rodrigues de Oliveira Filho, Gustavo de Oliveira Arouca, Josemberg Marins Campos
Format: Article
Language:English
Published: Sociedade Brasileira de Anestesiologia
Series:Revista Brasileira de Anestesiologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942018000300219&lng=en&tlng=en
_version_ 1818043413559246848
author Nádia Maria da Conceição Duarte
Ana Maria Menezes Caetano
Silvio da Silva Caldas Neto
Getúlio Rodrigues de Oliveira Filho
Gustavo de Oliveira Arouca
Josemberg Marins Campos
author_facet Nádia Maria da Conceição Duarte
Ana Maria Menezes Caetano
Silvio da Silva Caldas Neto
Getúlio Rodrigues de Oliveira Filho
Gustavo de Oliveira Arouca
Josemberg Marins Campos
author_sort Nádia Maria da Conceição Duarte
collection DOAJ
description Abstract Background and objectives: The weight parameters for use of sugammadex in morbidly obese patients still need to be defined. Methods: A prospective clinical trial was conducted with sixty participants with body mass index ≥ 40 kg.m-2 during bariatric surgery, randomized into three groups: ideal weight (IW), 20% corrected body weight (CW20) and 40% corrected body weight (CW40). All patients received total intravenous anesthesia. Rocuronium was administered at dose of 0.6 mg.kg-1 of Ideal weight for tracheal intubation, followed by infusion of 0.3-0.6 mg.kg-1.h-1. Train of four (TOF) was used to monitor depth of blockade. After spontaneous recovery TOF-count 2 at the end of surgery, 2 mg.kg-1 of sugammadex was administered. Primary outcome was neuromuscular blockade reversal time to TOF ≥ 0.9. Secondary outcome was the occurrence of postoperative residual curarization in post-anesthesia recovery room, searching the patient's ability to pass from the surgical bed to the transport, adequacy of oxygenation, respiratory pattern, ability to swallow saliva and clarity of vision. Results: Groups were homogenous in gender, age, total body weight, ideal body weight, body mass index, type and time of surgery. The reversal times (s) were (mean ± standard deviation) 225.2 ± 81.2, 173.9 ± 86.8 and 174.1 ± 74.9 respectively, in the IW, CW20 and CW40 groups (p = 0.087). Conclusions: No differences were observed between groups with neuromuscular blockade reversal time and frequency of postoperative residual curarization. We concluded that ideal body weight can be used to calculate sugammadex dose to reverse moderate neuromuscular blockade in morbidly obese patients.
first_indexed 2024-12-10T09:01:49Z
format Article
id doaj.art-4cd77a15658b4b079dfd469118e655d5
institution Directory Open Access Journal
issn 1806-907X
language English
last_indexed 2024-12-10T09:01:49Z
publisher Sociedade Brasileira de Anestesiologia
record_format Article
series Revista Brasileira de Anestesiologia
spelling doaj.art-4cd77a15658b4b079dfd469118e655d52022-12-22T01:55:14ZengSociedade Brasileira de AnestesiologiaRevista Brasileira de Anestesiologia1806-907X68321922410.1016/j.bjane.2017.10.011S0034-70942018000300219Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trialNádia Maria da Conceição DuarteAna Maria Menezes CaetanoSilvio da Silva Caldas NetoGetúlio Rodrigues de Oliveira FilhoGustavo de Oliveira AroucaJosemberg Marins CamposAbstract Background and objectives: The weight parameters for use of sugammadex in morbidly obese patients still need to be defined. Methods: A prospective clinical trial was conducted with sixty participants with body mass index ≥ 40 kg.m-2 during bariatric surgery, randomized into three groups: ideal weight (IW), 20% corrected body weight (CW20) and 40% corrected body weight (CW40). All patients received total intravenous anesthesia. Rocuronium was administered at dose of 0.6 mg.kg-1 of Ideal weight for tracheal intubation, followed by infusion of 0.3-0.6 mg.kg-1.h-1. Train of four (TOF) was used to monitor depth of blockade. After spontaneous recovery TOF-count 2 at the end of surgery, 2 mg.kg-1 of sugammadex was administered. Primary outcome was neuromuscular blockade reversal time to TOF ≥ 0.9. Secondary outcome was the occurrence of postoperative residual curarization in post-anesthesia recovery room, searching the patient's ability to pass from the surgical bed to the transport, adequacy of oxygenation, respiratory pattern, ability to swallow saliva and clarity of vision. Results: Groups were homogenous in gender, age, total body weight, ideal body weight, body mass index, type and time of surgery. The reversal times (s) were (mean ± standard deviation) 225.2 ± 81.2, 173.9 ± 86.8 and 174.1 ± 74.9 respectively, in the IW, CW20 and CW40 groups (p = 0.087). Conclusions: No differences were observed between groups with neuromuscular blockade reversal time and frequency of postoperative residual curarization. We concluded that ideal body weight can be used to calculate sugammadex dose to reverse moderate neuromuscular blockade in morbidly obese patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942018000300219&lng=en&tlng=enSugamadexCirurgia bariátricaPeso corporalBloqueio neuromuscularCurarização residual pós-operatória
spellingShingle Nádia Maria da Conceição Duarte
Ana Maria Menezes Caetano
Silvio da Silva Caldas Neto
Getúlio Rodrigues de Oliveira Filho
Gustavo de Oliveira Arouca
Josemberg Marins Campos
Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial
Revista Brasileira de Anestesiologia
Sugamadex
Cirurgia bariátrica
Peso corporal
Bloqueio neuromuscular
Curarização residual pós-operatória
title Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial
title_full Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial
title_fullStr Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial
title_full_unstemmed Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial
title_short Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial
title_sort sugammadex by ideal body weight versus 20 and 40 corrected weight in bariatric surgery double blind randomized clinical trial
topic Sugamadex
Cirurgia bariátrica
Peso corporal
Bloqueio neuromuscular
Curarização residual pós-operatória
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942018000300219&lng=en&tlng=en
work_keys_str_mv AT nadiamariadaconceicaoduarte sugammadexbyidealbodyweightversus20and40correctedweightinbariatricsurgerydoubleblindrandomizedclinicaltrial
AT anamariamenezescaetano sugammadexbyidealbodyweightversus20and40correctedweightinbariatricsurgerydoubleblindrandomizedclinicaltrial
AT silviodasilvacaldasneto sugammadexbyidealbodyweightversus20and40correctedweightinbariatricsurgerydoubleblindrandomizedclinicaltrial
AT getuliorodriguesdeoliveirafilho sugammadexbyidealbodyweightversus20and40correctedweightinbariatricsurgerydoubleblindrandomizedclinicaltrial
AT gustavodeoliveiraarouca sugammadexbyidealbodyweightversus20and40correctedweightinbariatricsurgerydoubleblindrandomizedclinicaltrial
AT josembergmarinscampos sugammadexbyidealbodyweightversus20and40correctedweightinbariatricsurgerydoubleblindrandomizedclinicaltrial